Taiwan study hunts for hidden genetic clues in rare stomach cancer
NCT ID NCT04821895
First seen Jun 25, 2026 · Last updated Jul 02, 2026 · Updated 2 times
Summary
This study looks at the genetic makeup of a rare stomach cancer called gastrointestinal stromal tumor (GIST) in patients whose tumors lack common mutations. Researchers will analyze tumor samples from 50 people in Taiwan to find other genetic changes that might be treatable. The goal is to understand why some GISTs don't respond to standard drugs and to discover new treatment options.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could reveal new genetic targets for treating wild type GIST, potentially leading to better therapies for this rare cancer.
- What could go wrong
- This is a small, early-stage observational study, not a treatment trial. It may not identify actionable genetic changes, and any findings would need further research to confirm.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GASTROINTESTINAL STROMAL TUMOR (GIST) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Chang Gung Memorial Hospital
Kaohsiung City, Taiwan
-
Chang Gung Memorial Hospital
Taoyuan, Taiwan
-
China Medical University Hospital
Taichung, Taiwan
-
Kaohsiung Medical University Chung-Ho Memorial Hospital
Kaohsiung City, Taiwan
-
Kaohsiung Veterans General Hospital
Kaohsiung City, Taiwan
-
Mackay Memorial Hospital
Taipei, Taiwan
-
National Cheng Kung University Hospital
Tainan, Taiwan
-
National Taiwan University Hospital
Taipei, Taiwan
-
Taichung Veterans General Hospital
Taichung, Taiwan
-
Taipei Veterans General Hospital
Taipei, Taiwan
-
Tri-Service General Hospital
Taipei, Taiwan
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Metabolic MRI may reveal tumor response to GIST drug in weeks, not months
- Massive GIST registry aims to unlock secrets of rare cancer
- Blood test may guide cancer care without biopsy
- New pill HQP1351 enters human testing for stubborn cancers
- New surgery aims to remove stomach tumors without major incisions
- New targeted drug takes on stomach cancer in Head-to-Head trial